Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 329 entries
View as:

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02203552 Org: User:
Start: 06/23/15 End: 06/15/20 Due: 06/15/21

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01975363 Org: User:
Start: 06/30/13 End: 09/19/16 Due: 09/19/17

Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06233253 Org: User:
Start: 09/29/23 End: 07/12/24 Due: 07/12/25

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01764802 Org: User:
Start: 10/31/10 End: 06/01/17 Due: 06/01/18

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT01521039 Org: User:
Start: 02/20/12 End: 12/30/24 Due: 12/30/25

A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05342571 Org: User:
Start: 06/01/21 End: 09/01/22 Due: 09/01/23

Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02262325 Org: User:
Start: 06/08/15 End: 04/15/24 Due: 04/15/25

Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease

Phase: N/A Priority: Normal
NCT ID: NCT01656746 Org: User:
Start: 05/31/10 End: 10/31/13 Due: 10/31/14

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02150525 Org: User:
Start: 08/31/10 End: 01/31/13 Due: 01/31/14

Biomarker Identification for Bladder Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02053662 Org: User:
Start: 01/21/14 End: 11/16/23 Due: 11/16/24

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00017199 Org: User:
Start: 04/30/01 End: 05/31/07 Due: 05/31/08

Nipple Aspirate Fluid in Detecting Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03715959 Org: User:
Start: 12/10/20 End: 01/01/24 Due: 01/01/25

Intensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02050906 Org: User:
Start: 05/21/13 End: 07/29/15 Due: 07/29/16

Expiratory Muscle Strength Training in Improving Bulbar Function and Quality of Life in Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03175289 Org: User:
Start: 09/29/16 End: 01/03/19 Due: 01/03/20

Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02722525 Org: User:
Start: 12/31/14 End: 12/31/25 Due: 12/31/26

Hookah Additive Research to Inform Product Standards

Phase: N/A Priority: Normal
NCT ID: NCT05453773 Org: User:
Start: 06/19/22 End: 05/11/23 Due: 05/11/24

Inspiratory Muscle Training in Obese Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05193149 Org: User:
Start: 11/13/23 End: 06/30/29 Due: 06/30/30

Venetoclax and Ibrutinib in Treating in Participants with Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations

Phase: N/A Priority: Normal
NCT ID: NCT03513562 Org: User:
Start: 03/26/19 End: 12/31/25 Due: 12/31/26

Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk

Phase: N/A Priority: Normal
NCT ID: NCT01559194 Org: User:
Start: 05/31/05 End: 12/31/07 Due: 12/31/08

Examination of Low Wattage and High Wattage E-Cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT03113136 Org: User:
Start: 06/29/17 End: 01/31/22 Due: 01/31/23

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT06964737 Org: User:
Start: 07/01/25 End: 12/31/26 Due: 12/31/27

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06323460 Org: User:
Start: 03/21/24 End: 12/31/25 Due: 12/31/26

Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01644136 Org: User:
Start: 07/14/11 End: 05/06/14 Due: 05/06/15

Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study

Phase: N/A Priority: Normal
NCT ID: NCT05455086 Org: User:
Start: 03/23/22 End: 06/26/23 Due: 06/26/24

Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers

Phase: N/A Priority: Normal
NCT ID: NCT06644664 Org: User:
Start: 09/24/24 End: 12/31/26 Due: 12/31/27